M, S., A, R., JM, X., MH, W., Y, A., PR, H., & FA, H. (2019). Design, creation and in vitro testing of a reduced immunogenicity humanized anti-CD25 monoclonal antibody that retains functional activity. Protein engineering, design & selection : PEDS, 32(12), 543. https://doi.org/10.1093/protein/gzaa017
Chicago Style (17th ed.) CitationM, Stickler, Reddy A, Xiong JM, Wong MH, Akamatsu Y, Hinton PR, and Harding FA. "Design, Creation and in Vitro Testing of a Reduced Immunogenicity Humanized Anti-CD25 Monoclonal Antibody That Retains Functional Activity." Protein Engineering, Design & Selection : PEDS 32, no. 12 (2019): 543. https://doi.org/10.1093/protein/gzaa017.
MLA (9th ed.) CitationM, Stickler, et al. "Design, Creation and in Vitro Testing of a Reduced Immunogenicity Humanized Anti-CD25 Monoclonal Antibody That Retains Functional Activity." Protein Engineering, Design & Selection : PEDS, vol. 32, no. 12, 2019, p. 543, https://doi.org/10.1093/protein/gzaa017.